471 completed, 128 recruiting, 125 unknown, 63 terminated. 483 Not applicable, 95 Phase 3, 86 Phase 2, 47 Phase 1, 23 Phase 4.
Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Efficacy of Saccadic and Biofeedback Training in Homonymous Hemianopia Biofeedback Fixation Training, Saccadic Reading Training - Hemianopia, Homonymous | Not applicable | Suspended | University of Alabama at Birmingham | 20 | 2027-06-01 | 2026-09-25 |
| joyVision: The Superiority of Co-design in the Development of a Serious Game for Children With Cerebral Visual Impairment serious game - Cerebral Visual Impairment | Not applicable | Not yet recruiting | Universitaire Ziekenhuizen KU Leuven | 34 | 2027-06-01 | 2026-10-26 |
| Remapping Text in Sentence and Word Tasks to Aid Reading With Central Vision Loss Personalised Remapping Training, RSVP personalized remappi, Reading text in the wild with remapping - Macular Degeneration, Central Visual Impairment | Not applicable | Not yet recruiting | University of Minnesota | 216 | 2027-06-01 | 2026-10-29 |
| Body Image, Identity Development, and Social Media Use Among Youth With Visual Impairment: A Single Case Intervention Study Body image intervention - Visual Impairment, Cerebral Visual Impairment | Not applicable | Not yet recruiting | Universitaire Ziekenhuizen KU Leuven | 15 | 2027-05-01 | 2026-08-03 |
| Eye Health Intervention Study in Upper Manhattan Intervention, Usual Care - Glaucoma, Suspect, Diabetic Retinopathy | Not applicable | Withdrawn | Columbia University | 2027-04-01 | 2026-05-29 | |
| A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus) Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus) | Phase 1 / Phase 2 | Not yet recruiting | George Washington University | 24 | 2027-03-01 | 2026-10-05 |
| Promoting Psychophysical Well-being in Children and Adolescents With Visual Impairment Adapted Physical Activity Programme - Visual Impairment, Cerebral Visual Impairment | Not applicable | Not yet recruiting | Università degli Studi di Trento | 20 | 2027-01-01 | 2026-07-14 |
| Ameliorating Stroke-induced Hemianopia Via Multisensory Training Multisensory Training, Unisensory Training - Hemianopia, Homonymous, Cortical Blindness, Unspecified Side of Brain | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 72 | 2027-01-01 | 2026-10-23 |
| Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour Visual Stimulation, standard of care - Hemianopsia, Virtual Reality | Not applicable | Not yet recruiting | Institut National de la Santé Et de la Recherche Médicale, France | 120 | 2026-12-01 | 2026-09-16 |
| Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors SONDA - Pituitary Tumor, Visual Fields Hemianopsia | Not yet recruiting | University Medical Center Groningen | 30 | 2026-12-01 | 2026-07-23 | |
| 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome N-acetylcysteine amide, Placebo - Retinitis Pigmentosa (RP), Usher Syndrome | Phase 3 | Not yet recruiting | Nacuity Pharmaceuticals, Inc. | 80 | 2026-12-01 | 2026-07-01 |
| NEURO-COGS: Neurometabolic Mechanisms of Cognitive Training in Schizophrenia Perceptual Discrimination Training, Cognitive Control Training - Schizophrenia, Schizoaffective Disorder | Not applicable | Not yet recruiting | University of Minnesota | 168 | 2026-11-02 | 2026-10-02 |
| Visual Restoration Using Focused Ultrasound Stimulation and Immersive Virtual Reality After Stroke Low-intensity focused ultrasound, Immersive virtual reality, Inactive Low-intensity focused ultrasound - Stroke, Visual Field Defect | Not applicable | Not yet recruiting | Duke University | 28 | 2026-11-01 | 2026-08-24 |
| Attention-based Binocular Training for Impaired Stereopsis (BRAVE) Attention-Guided Dichoptic Visual Search Training, Zero-Disparity Dichoptic Visual Search Task - Amblyopia, Strabismus | Not applicable | Not yet recruiting | Centre for Eye and Vision Research | 56 | 2026-11-01 | 2026-09-03 |
| Non-invasive Induction of Metaplasticity for Amblyopia Flicker - Amblyopia, Amblyopia Unilateral | Not applicable | Not yet recruiting | Boston Children's Hospital | 10 | 2026-11-01 | 2026-09-29 |
| SENSE-Brain Health Pro for Older Adults With Sensory Loss Brain Health Pro - Vision and Hearing Loss, Vision Impairment | Not applicable | Not yet recruiting | Université de Montréal | 300 | 2026-10-15 | 2026-10-05 |
| Pilot Study of Individualized Neurovisual Rehabilitation Following Acquired Brain Injury Individualized Neurovisual Rehabilitation - Brain Injuries | Not applicable | Not yet recruiting | Charles University, Czech Republic | 30 | 2026-10-15 | 2026-09-30 |
| Study to Evaluate the Long-Term Safety of Ultevursen in Participants With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene No intervention, will not receive any active study intervention, Intravitreal Injection of Ultevursen - Retinitis Pigmentosa (RP), Usher Syndrome Type 2 | Phase 2 | Not yet recruiting | Laboratoires Thea | 81 | 2026-10-05 | 2026-09-01 |
| Anatomical and Functional Predictions of Blindsight Capabilities in Patients With Lateral Hemianopsia Homonymous Hemianopia, Stroke | Not yet recruiting | Fondation Ophtalmologique Adolphe de Rothschild | 50 | 2026-10-01 | 2026-10-01 | |
| Effects of Optokinetic Stimulation Without a Reading Task in Patients With Hemianopic Alexia Optokinetic stimulation without reading task, Optokinetic stimulation with reading task - Hemianopia Homonymous, Stroke | Not applicable | Not yet recruiting | Clinique Les Trois Soleils | 30 | 2026-10-01 | 2026-09-21 |
Showing 20 of 942. Sign in to see all of them.
Amblyopia (182) · Blindness (141) · Vision, Low (91) · Macular Degeneration (74) · Hemianopsia (63) · Color Vision Defects (62) · Eye Diseases (60) · Blindness, Cortical (51) · Retinal Diseases (48) · Retinitis Pigmentosa (45) · Photophobia (43) · Stroke (40) · Strabismus (35) · Usher Syndromes (33)
Neurologic Manifestations (935) · Nervous System Diseases (934) · Pathological Conditions, Signs and Symptoms (931) · Sensation Disorders (931) · Signs and Symptoms (929) · Eye Diseases (882) · Central Nervous System Diseases (310) · Brain Diseases (301) · Blindness (153) · Retinal Diseases (153) · Eye Diseases, Hereditary (145) · Retinal Degeneration (127) · Cardiovascular Diseases (120) · Vascular Diseases (114)
Ranibizumab (26) · aflibercept (19) · salicylhydroxamic acid (16) · Eyeglasses (11) · Atropine (10) · Transcranial Direct Current Stimulation (10) · brolucizumab (10) · Cognitive Behavioral Therapy (6) · Dexamethasone (6) · Melatonin (6) · Therapeutics (5) · rimegepant sulfate (5) · Calcium Dobesilate (4) · Intravitreal Injections (4) · Lasers (4)
Novartis Pharmaceuticals (32) · Jaeb Center for Health Research (26) · National Eye Institute (NEI) (19) · Massachusetts Eye and Ear Infirmary (11) · University of Alabama at Birmingham (11) · Johns Hopkins University (10) · US Department of Veterans Affairs (10) · Fondation Ophtalmologique Adolphe de Rothschild (9) · Adverum Biotechnologies, Inc. (8) · Pfizer (8) · University of Rochester (8) · Kodiak Sciences Inc (7) · Laboratoires Thea (7) · National Taiwan University Hospital (7) · Universitaire Ziekenhuizen KU Leuven (7)
United States (401) · United Kingdom (77) · France (75) · Canada (58) · Germany (55) · China (54) · Spain (43) · Italy (39) · Netherlands (31) · Turkey (Türkiye) (27) · Israel (20) · Pakistan (20) · Poland (19) · Belgium (18) · Switzerland (17)
Pablo Velazquez-Martin, MD (7) · David K. Wallace, M.D. (5) · Georgios Labiris, MD, PhD (5) · Adam Turpcu, PhD (4) · Nancy Rocheleau, Program Analyst (4) · Alfred J Lewy, MD, PhD (3) · Ava K Bittner, OD, PhD (3) · David A Ross, MSEE Med (3) · Dennis M Levi, OD, PhD (3) · Farooq Naeem, MRCPsych (3) · Huibert J Simonsz, MD, PhD (3)
PMID 20451898, PMID 22108357, PMID 37619861, PMID 15824215, PMID 19109504, PMID 21912514, PMID 17027061, PMID 18824189, PMID 19008199, PMID 22558234, PMID 22562517, PMID 22965590, PMID 23060759, PMID 23706949, PMID 23882695, PMID 24150759, PMID 24271326, PMID 24768239, PMID 25148789, PMID 25715870, PMID 25812924, PMID 26050541, PMID 26152053, PMID 26452713, PMID 26466871, PMID 26584450, PMID 26613827, PMID 26909178, PMID 26992841, PMID 27234930, PMID 28824369, PMID 29752001, PMID 30419298, PMID 31047350, PMID 31047503, PMID 31668888, PMID 32300295, PMID 32318673, PMID 33102611, PMID 34239634, PMID 34770374, PMID 35129211, PMID 35917136, PMID 36067410, PMID 36774994, PMID 36951854, PMID 37314061, PMID 37585454, PMID 38917142, PMID 39680390
U10EY011751 (21), 2018 (6), 2019 (4), R01EY031777 (4), 2014 (3), 2016 (3), 2UG1EY011751 (3), R01EY022313 (3), 2023 (2), R01EY001728 (2), R01EY023385 (2), R01EY027314 (2), R01HD042125 (2), R24EY022023 (2), 1UG1EY033293 (1)